Text Size

Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography Versus MRI

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Emory University.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Emory University
ClinicalTrials.gov Identifier:
NCT00166179
First received: September 13, 2005
Last updated: January 5, 2006
Last verified: September 2005
History of Changes
  Purpose

The purpose of this study is to compare cardiac MRI with positron emission tomography (PET) with fluorodeoxyglucose (FDG) to determine if cardiac MRI images are as good as, or better, than PET with FDG.


Condition Intervention
Coronary Artery Disease
 Procedure: MRI

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Comparison of Myocardial Viability by Positron Emission Tomography Versus Contrast-Enhanced Cardiac Magnetic Resonance Imaging

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Emory University:

Estimated Enrollment: 70
Study Start Date: November 2003
  Eligibility

Ages Eligible for Study:   18 Years to 95 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • PET with FDG ordered

Exclusion Criteria:

  • Contraindicated for MRI
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00166179

Contacts
Contact: Rebecca Knoff, RN 404-686-1825 rebecca.knoff@emoryhealthcare.org
Contact: Kristen Moehring, RN 404-686-7289 kristen.moehring@emoryhealthcare.org

Locations
United States, Georgia
Crawford Long Hospital Recruiting
Atlanta, Georgia, United States, 30308
Contact: Rebecca Knoff, RN     404-686-1825     rebecca.knoff@emoryhealthcare.org    
Sponsors and Collaborators
Emory University
Investigators
Principal Investigator: Randolph Patterson, MD Staff
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00166179     History of Changes
Other Study ID Numbers: 6-56550
Study First Received: September 13, 2005
Last Updated: January 5, 2006
Health Authority: United States: Institutional Review Board

Keywords provided by Emory University:
CAD

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
 Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on May 16, 2013